ASND - Rasio utang marang kapitalisasi buku Ascendis Pharma AS

Ascendis Pharma A/S (ASND) is making the therapy for rare endocrine disorders more convenient, fostering strong brand loyalty. On the GURU.Markets platform, the company's debt-to-book capitalization ratio demonstrates capital dynamics, where 0.32 captures the current value of the indicator. This is based on the TransCon system, which establishes closed treatment standards, and active R&D with high efficiency in launching new products.

ASND (Ascendis) riwayat Utang marang nilai buku saka 04.07.2022 nganti 27.10.2026

Ascendis Pharma AS (ASND) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:

Rega saham Ascendis Pharma A/S|ASND - Prakiraan konsensus analis

- data kapitalisasi pasar:

Nilai pasar Ascendis|ASND - Nilai Dipunlarasaken Utang lan Kas

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Ascendis Pharma|ASND - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku ascendispharma.com|ASND - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas Ascendis Pharma A/S|ASND - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Ascendis Pharma Inc.|ASND - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Ascendis

Analisis fundamental perusahaan:Ascendis Pharma A/S - ASND

This ratio compares total debt obligations to the market value of equity, allowing for an assessment of the actual level of financial leverage within the price action. By analyzing the history of the debt-to-equity ratio, an investor can see the resilience of Ascendis Pharma (ASND), which prefers organic growth and partnerships over mergers, thereby minimizing the risk of overloading the balance sheet with borrowed capital while scaling technologies.

Pesaing Ascendis Pharma A/S (ASND)